The EVP of Integrated Supply Chain of Becton Dickinson (BDX) is Selling Shares
Today, the EVP of Integrated Supply Chain of Becton Dickinson (BDX), Alexandre Conroy, sold shares of BDX for $2.51M.
Following Alexandre Conroy’s last BDX Sell transaction on February 15, 2017, the stock climbed by 78.9%. In addition to Alexandre Conroy, 2 other BDX executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Becton Dickinson’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $4.35 billion and quarterly net profit of $451 million. In comparison, last year the company earned revenue of $4.28 billion and had a net profit of $594 million. The company has a one-year high of $265.87 and a one-year low of $208.62. BDX’s market cap is $68.3B and the company has a P/E ratio of 89.49.
The insider sentiment on Becton Dickinson has been negative according to 77 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Becton, Dickinson & Co. is a global medical technology company. The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.